ALKS
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
Head of Investor Relations
Alkermes plc. (ALKS)Equibles does not estimate personal net worth.
Get an email with a short summary when Alkermes plc. publishes a filing, an earnings call transcript or a press release.
Get ALKS alertsSandy Coombs is recorded as Head of Investor Relations at Alkermes plc. (ALKS). Sandy Coombs has spoken on 2 earnings calls across 1 company, most recently for Alkermes plc. on February 25, 2026. Alkermes plc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Alkermes plc. includes Blair C. Jackson (CEO, CFO and COO), Mr. Richard F. Pops (CEO), Iain M. Brown (CFO and Chief Accounting Officer) and 7 others.
“Welcome to the Alchemist PLC conference call to discuss our financial results and business update for the quarter and year-ended December 31, 2025.”
“Welcome to the Alkermes Plc conference call to discuss our financial results and business update for the quarter ended March 31, 2025. With me today are Richard Pops, our CEO; Todd Nichols, our Chief Commercial Officer; Blair Jackson, our Chief Operating Officer; and Dr. Craig Hopkinson, our Chief Medical Officer.”
ALKS
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations